We are proud to announce the launch of Gnomica Biotherapy, a new biotech company emerging from discoveries made in Ravid Straussman's lab at the Weizmann Institute of Science!

Gnomica is pioneering a novel approach to cancer treatment, developing small-molecule drug inhibitors targeting bacterial functions in the human body, a critical and often overlooked factor in treatment resistance.

The company was co-founded by an exceptional and highly experienced team: Uri Kolodny, Yuval Raviv, and Ravid Straussman
Wishing this stellar team every success in their mission to transform cancer therapy and ultimately to save lives.